TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21521283

Group type: EXPERIMENTAL
Intervention: Testosterone gel (5 or 10 g/daily) plus rhGH (0, 3 or 5 μg/kg/day)
Number of subjects: 108
Study: 19396567

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 0
Study: 16702472

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE; 0.625 mg; n=5310)
Number of subjects: 10739

Group type: COMPARATOR
Intervention: Placebo (n=5429)
Number of subjects: 10739

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE; 0.625 mg)
Number of subjects: 10739
Study: 15588333

Group type: EXPERIMENTAL
Intervention: Duhuo Jisheng Wan (DJW)
Number of subjects: 200

Group type: COMPARATOR
Intervention: diclofenac
Number of subjects: 200
Study: 11498833

Group type: EXPERIMENTAL
Intervention: Radiation therapy to the ipsilateral breast
Number of subjects: 2622

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) after lumpectomy and radiation therapy
Number of subjects: 2622

Group type: COMPARATOR
Intervention: Lumpectomy alone
Number of subjects: 2622

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 2622
Study: 9515223

Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 100 mg preprandial
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 200 mg preprandial
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 300 mg preprandial
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 200 mg postprandial
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 200 mg every 12 hours for 7 days
Number of subjects: 5
Study: 8427430

Group type: EXPERIMENTAL
Intervention: Metoclopramide + Placebos
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoclopramide + Ibuprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebos + Placebos
Number of subjects: 0
Study: 3679703

Group type: EXPERIMENTAL
Intervention: 50 mg elemental zinc/day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 100 mg elemental zinc/day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 150 mg elemental zinc/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (young females)
Number of subjects: 15
Study: 29429948

Group type: EXPERIMENTAL
Intervention: VR-CBT (16 individual therapy sessions, each 1 hour long)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Waiting list control (treatment as usual)
Number of subjects: 116
Study: 27222342

Group type: EXPERIMENTAL
Intervention: Caffeine solution during 180 min of stationary cycling
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo during 180 min of stationary cycling
Number of subjects: 11
Study: 24299727

Group type: EXPERIMENTAL
Intervention: G‐CSF (10 μg/kg/d) intravenously for 5 consecutive days
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no G‐CSF administration)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: G‐CSF group
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 24354675

Group type: EXPERIMENTAL
Intervention: Korean red ginseng (KRG) 500 mg, six capsules twice a day for eight weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo, six capsules twice a day for eight weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Korean red ginseng (KRG)
Number of subjects: 80
Study: 20846227

Group type: EXPERIMENTAL
Intervention: Antenatal pelvic floor muscle exercises (4 sessions of taught training during pregnancy and 8-12 maximal contractions twice daily at home)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 286
Study: 18073463

Group type: EXPERIMENTAL
Intervention: Brachial artery (BrA) insonation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Common carotid artery (CCA) insonation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Common femoral artery (CFA) insonation
Number of subjects: 66
Study: 16033646

Group type: EXPERIMENTAL
Intervention: Information package (intervention arm)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: No information above that gained during normal practice (control arm)
Number of subjects: 1800
Study: 12297896

Group type: EXPERIMENTAL
Intervention: Iodine-enriched formula-milk (for preterm neonates)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Breast-milk
Number of subjects: 155

Group type: COMPARATOR
Intervention: Full term neonates (baseline measurement)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Full term neonates (historical comparison)
Number of subjects: 155
Study: 10077371

Group type: EXPERIMENTAL
Intervention: Direct bronchial artery revascularization
Number of subjects: 25

Group type: COMPARATOR
Intervention: No direct bronchial artery revascularization
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Excessive secretion in the airways
Number of subjects: 25
Study: 8824655

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 208

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 208
Study: 2033138

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 0.1% cream, applied once daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Hydrocortisone 1.0% cream, applied twice daily
Number of subjects: 48
Study: 7012247

Group type: EXPERIMENTAL
Intervention: Single-dose ampicillin (100 mg/kg)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Five-day multiple-dose ampicillin (100 mg/kg per 24 hr)
Number of subjects: 101
Study: 30717465

Group type: EXPERIMENTAL
Intervention: Education-based intervention
Number of subjects: 464
Study: 28388942

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Small-incision open cholecystectomy (SIOC)
Number of subjects: 323
Study: 25395689

Group type: EXPERIMENTAL
Intervention: Intramuscular droperidol (10 mg)
Number of subjects: 584

Group type: COMPARATOR
Intervention: Intramuscular haloperidol (10 mg)
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 584
Study: 24740868

Group type: EXPERIMENTAL
Intervention: 16-session lifestyle intervention delivered via 'video-on-demand' cable television
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: 16-session lifestyle intervention delivered via 'video-on-demand' cable television with online behavioral support tools
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 306
Study: 22986010

Group type: EXPERIMENTAL
Intervention: Disulfiram (DIS) for at least 120 days
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: DIS for <120 days
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: >50% adherence to consultations
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: More than two phases on each consultation
Number of subjects: 209

Group type: COMPARATOR
Intervention: Female gender, lower socio‐economic levels, cocaine use, >20 years of consumption, gamma glutamyl transferase values above normal, five or more alcohol-related problems
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Having a full-time job and shorter abstinence time before treatment (until 7 days)
Number of subjects: 209
Study: 20067599

Group type: EXPERIMENTAL
Intervention: Renal replacement therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contrast-induced nephropathy protection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimization of volume status, haemodynamic parameters, electrolyte and acid-base disturbances
Number of subjects: 0
Study: 16368629

Group type: EXPERIMENTAL
Intervention: Motivational music
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Rhythm music
Number of subjects: 58

Group type: COMPARATOR
Intervention: No music
Number of subjects: 58
Study: 12941676

Group type: EXPERIMENTAL
Intervention: 0.25 mg/d of micronized 17beta-estradiol (n = 83)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo (n = 84)
Number of subjects: 167
Study: 11899388

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 given as a 3-hour infusion every 3 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Paclitaxel with trastuzumab
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Docetaxel 60-100 mg/m2 given as a 1-hour infusion every 3 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Taxanes as a component of first-line therapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Taxanes (Paclitaxel and Docetaxel)
Number of subjects: 18
Study: 8888110

Group type: EXPERIMENTAL
Intervention: Desipramine (200 mg/day for 6 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 12
Study: 1473367

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP; 200‐300 mg, i.v. b.i.d.) + vancomycin (VAN; 0.5‐1 g, i.v. b.i.d.)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Ceftazidime (2 g, i.v. t.i.d.) + gentamicin (1 mg/kg, i.v. t.i.d.)
Number of subjects: 58
Study: 6657514

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP) 60 micrograms
Number of subjects: 15

Group type: COMPARATOR
Intervention: Vehicle solution
Number of subjects: 15
Study: 31630465

Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided erector spinae plane block using 0.3 mL/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received general anesthesia with bilateral sham erector spinae plane block using 0.3 mL/kg normal saline on each side
Number of subjects: 60
Study: 28921547

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide (HP) for 1.5 hours daily for 21 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: 10% carbamide peroxide (CP) for 4 hours daily for 21 days
Number of subjects: 30
Study: 27505216

Group type: EXPERIMENTAL
Intervention: Go/no-go food task
Number of subjects: 133

Group type: COMPARATOR
Intervention: Go/no-go control task
Number of subjects: 133
Study: 25071901

Group type: EXPERIMENTAL
Intervention: rebamipide 100 mg three times per day
Number of subjects: 479

Group type: COMPARATOR
Intervention: misoprostol 200 μg three times per day
Number of subjects: 479
Study: 22916885

Group type: EXPERIMENTAL
Intervention: Fermented milk supplemented with Bifidobacterium lactis Bi‐07 and Lactobacillus acidophilus NCFM, and isomaltooligosaccharide, 480 g/d for 2 weeks
Number of subjects: 100
Study: 20708525

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 microg per day)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 166

Group type: COMPARATOR
Intervention: Selenium supplementation and Placebo
Number of subjects: 166
Study: 17767826

Group type: EXPERIMENTAL
Intervention: Thermal-softened tube guided by fiberoptic bronchoscope
Number of subjects: 209

Group type: COMPARATOR
Intervention: Common tube at room temperature (23-26 centigrade)
Number of subjects: 209
Study: 16230723

Group type: EXPERIMENTAL
Intervention: Antiseptic catheter (chlorhexidine and silver sulfadiazine)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Control catheter (standard catheter)
Number of subjects: 780
Study: 12110425

Group type: EXPERIMENTAL
Intervention: HRT (estradiol plus noretisterone acetate) for 1 year
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Exercise (jumping and bounding activities) for 1 year
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: HRT + Exercise (ExHRT) for 1 year
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (Co)
Number of subjects: 80
Study: 10543292

Group type: EXPERIMENTAL
Intervention: Inhaled Mannitol (300 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (6%)
Number of subjects: 12
Study: 7818312

Group type: EXPERIMENTAL
Intervention: Normothermic CPB (36 degrees C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hypothermic CPB (28 degrees C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 2127687

Group type: EXPERIMENTAL
Intervention: Protirelin tartrate (TRH-T)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 217789

Group type: EXPERIMENTAL
Intervention: Premarin Intravenous
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study: 31639016

Group type: EXPERIMENTAL
Intervention: Comprehensive health program (medical exercise therapy and lifestyle coaching)
Number of subjects: 552

Group type: COMPARATOR
Intervention: Longitudinal back pain survey (control group)
Number of subjects: 552
Study: 28410525

Group type: EXPERIMENTAL
Intervention: Real rTMS (10Hz)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study: 26487563

Group type: EXPERIMENTAL
Intervention: weight-loss program + exercise (WL + E group)
Number of subjects: 55

Group type: COMPARATOR
Intervention: weight-loss program + sham (WL + S group)
Number of subjects: 55
Study: 22516427

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (aspirin 325 mg daily plus clopidogrel 75 mg daily)
Number of subjects: 3020

Group type: COMPARATOR
Intervention: Antiplatelet therapy (aspirin 325 mg daily plus placebo)
Number of subjects: 3020

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure targets (<130 mmHg)
Number of subjects: 3020

Group type: COMPARATOR
Intervention: Usual systolic blood pressure targets (130‐149 mmHg)
Number of subjects: 3020
Study: 21496110

Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation (EMS) on dominant wrist flexors
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (conventional mode of transcutaneous electrical nerve stimulation without contraction)
Number of subjects: 23
Study: 19238387

Group type: EXPERIMENTAL
Intervention: TACE‐PVO (group B: n = 14)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Shunt embolization with coils and/or gelatin‐sponge particles (group A: n = 7)
Number of subjects: 21
Study: 16304567

Group type: EXPERIMENTAL
Intervention: Vibro-ejaculation weekly for 3 months (study group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Baseline and end of 3-month period vibro-ejaculation (control group)
Number of subjects: 74
Study: 12672933

Group type: EXPERIMENTAL
Intervention: Protein intake
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Carbohydrate intake
Number of subjects: 467
Study: 10732934

Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg/d) and pyrazinamide (20 mg/kg per day) for 2 months
Number of subjects: 1583

Group type: COMPARATOR
Intervention: Isoniazid (300 mg/d) for 12 months
Number of subjects: 1583

Group type: EXPERIMENTAL
Intervention: Rifampin and pyrazinamide
Number of subjects: 1583

Group type: COMPARATOR
Intervention: Isoniazid
Number of subjects: 1583
Study: 8609128

Group type: EXPERIMENTAL
Intervention: Group 1 (patients after total joint replacement)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Group 2 (control group before total joint replacement)
Number of subjects: 27
Study: 1575846

Group type: COMPARATOR
Intervention: Lidocaine DPNB
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Chloroprocaine DPNB (3-minute wait)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Chloroprocaine DPNB (2-minute wait)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Chloroprocaine DPNB (5-minute wait)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (nonblocked)
Number of subjects: 75
Study: 3881228

Group type: EXPERIMENTAL
Intervention: Diltiazem (60 mg, single oral dose)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 2
Study: 30889985

Group type: EXPERIMENTAL
Intervention: iPad (light)
Number of subjects: 14

Group type: COMPARATOR
Intervention: hard-copy book (control)
Number of subjects: 14
Study: 29471303

Group type: EXPERIMENTAL
Intervention: Awareness of the new kidney allocation system among dialysis facility staff
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Awareness by role among staff
Number of subjects: 653
Study: 27598552

Group type: EXPERIMENTAL
Intervention: Combination of pain education, specific exercises, and graded physical activity training
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pain education alone (control)
Number of subjects: 200
Study: 24988555

Group type: EXPERIMENTAL
Intervention: Epidural injections of glucocorticoids plus lidocaine
Number of subjects: 400

Group type: COMPARATOR
Intervention: Lidocaine alone
Number of subjects: 400
Study: 22162540

Group type: EXPERIMENTAL
Intervention: Trimetazidine 35-mg MR tablets in fasting state
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Trimetazidine 35-mg MR tablets in fed state
Number of subjects: 36

Group type: COMPARATOR
Intervention: Reference formulation in fasting state
Number of subjects: 36

Group type: COMPARATOR
Intervention: Reference formulation in fed state
Number of subjects: 36
Study: 19771385

Group type: EXPERIMENTAL
Intervention: Visceral peritoneal closure
Number of subjects: 620

Group type: COMPARATOR
Intervention: Non-closure
Number of subjects: 620
Study: 18456984

Group type: EXPERIMENTAL
Intervention: Continuum of care services
Number of subjects: 157

Group type: COMPARATOR
Intervention: Usual state-supported services
Number of subjects: 157
Study: 16281743

Group type: EXPERIMENTAL
Intervention: Pneumonectomy
Number of subjects: 0
Study: 12153550

Group type: EXPERIMENTAL
Intervention: Lisinopril (dosage not specified)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 447
Study: 11468536

Group type: COMPARATOR
Intervention: Tacrolimus and corticosteroids (MMF-0 group, n=82)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Tacrolimus, corticosteroids, and 1 g of MMF daily (MMF-1 g group, n=79)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Tacrolimus, corticosteroids, and 2 g of MMF daily (MMF-2 g group, n=71)
Number of subjects: 232
Study: 9780474

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 5 mg i.m. weekly for 24 months
Number of subjects: 42
Study: 7933425

Group type: EXPERIMENTAL
Intervention: 12 hours of surfactant per day
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 24 hours of surfactant per day
Number of subjects: 51

Group type: COMPARATOR
Intervention: 0.6% saline (12 hours per day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: 0.6% saline (24 hours per day)
Number of subjects: 51
Study: 3145585

Group type: EXPERIMENTAL
Intervention: Bretschneider cardioplegic HTK solution (group I)
Number of subjects: 249

Group type: COMPARATOR
Intervention: St. Thomas cardioplegic solution (group II)
Number of subjects: 249
Study: 29463280

Group type: EXPERIMENTAL
Intervention: 1 unit of platelet concentrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prophylactic platelet transfusion
Number of subjects: 0
Study: 27234930

Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.3 mg and 0.5 mg monthly)
Number of subjects: 745
Study: 23554353

Group type: EXPERIMENTAL
Intervention: Cold stimulation in BAT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin stimulation in BAT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold-induced glucose uptake after 5-month weight loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of detectable BAT
Number of subjects: 0
Study: 21056403

Group type: EXPERIMENTAL
Intervention: Immediate delivery
Number of subjects: 376

Group type: COMPARATOR
Intervention: Deferred delivery
Number of subjects: 376
Study: 18332474

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 5187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5187
Study: 17004564

Group type: EXPERIMENTAL
Intervention: Sealant
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Refurbishing
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Repair
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Replacement
Number of subjects: 66

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 66
Study: 14616818

Group type: EXPERIMENTAL
Intervention: Potassium titanyl phosphate (KTP) vascular laser
Number of subjects: 2

Group type: COMPARATOR
Intervention: Hyfrecator
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: KTP vascular laser
Number of subjects: 2
Study: 10808206

Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg/day p. o. or i.v.)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Amphotericin B (0.2 mg/kg/day i.v.)
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Fluconazole and Amphotericin B
Number of subjects: 355
Study: 8928757

Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor I (IGF-I, 10 micrograms.kg-1.h-1 sc) for 3 days
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor I (IGF-I)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8
Study: 1481646

Group type: EXPERIMENTAL
Intervention: Lisuride (1.3 mg mean daily dose, range 0.2-2.4 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bromocriptine (15 mg mean daily dose, range 3.75-30.0 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (levodopa and anticholinergic treatment unchanged)
Number of subjects: 20
Study: 29850971

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 99

Group type: COMPARATOR
Intervention: Audio book
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (sit quietly)
Number of subjects: 99
Study: 27565858

Group type: COMPARATOR
Intervention: Hyaluronic acid alone (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 × 10(6) cultured autologous BM‐MSCs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 100 × 10(6) cultured autologous BM‐MSCs
Number of subjects: 30
Study: 24284287

Group type: COMPARATOR
Intervention: TMP-SMX plus placebo
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: TMP-SMX plus doxycycline
Number of subjects: 626
Study: 23885605

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Lingtai (GV 10) and Shendao (GV 11)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Electroacupuncture at bilateral Xuanzhong (GB 39)
Number of subjects: 72
Study: 20510289

Group type: EXPERIMENTAL
Intervention: Multiple-exercise group (APE 2 times for 1 hr/wk)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-exercise group (APE 1 time for 1 hr/wk)
Number of subjects: 60
Study: 19770412

Group type: EXPERIMENTAL
Intervention: Electronic alert for VTE prophylaxis recommendation
Number of subjects: 1
Study: 16371612

Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg.kg‐1 mixed with acetaminophen suspension
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetaminophen alone (Control)
Number of subjects: 40